Clearmind Medicine Inc. Cash Flows From Used In Investing Activities
Clearmind Medicine Inc. (CMND) reported Cash Flows From Used In Investing Activities of -$542.02 thousand for the 12-month period ending 2025-10-31, per its 20-F filed 2026-01-20.
Financial Statements › Cash Flow › Investing Activities
ifrs-full:CashFlowsFromUsedInInvestingActivities · last filed 2026-03-12
CAD
| Period end | Cash Flows From Used In Investing Activities 12 month |
|---|---|
| 2022-10-31 | -7.59K CAD 20-F · filed 2023-02-06 |
| 2021-10-31 | -251.19K CAD 20-F · filed 2023-02-06 |
| 2020-10-31 | -5.09K CAD 20-F · filed 2023-02-06 |
USD
| Period end | Cash Flows From Used In Investing Activities 3 month | Cash Flows From Used In Investing Activities 6 month | Cash Flows From Used In Investing Activities 9 month | Cash Flows From Used In Investing Activities 12 month |
|---|---|---|---|---|
| 2025-10-31 | -$524.43K derived: 20-F 12 month − 6-K 9 month · filed 2026-01-20 | -$411.48K derived: sum of 2 quarters · filed 2026-01-20 | -$611.48K derived: sum of 3 quarters · filed 2026-01-20 | -$542.02K 20-F · filed 2026-01-20 |
| 2025-07-31 | $112.95K derived: 6-K 9 month − 6-K 6 month · filed 2025-09-11 | -$87.05K derived: sum of 2 quarters · filed 2025-09-11 | -$17.58K 6-K · filed 2025-09-11 | -$367.98K derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-04-30 | -$200.00K derived: 6-K 6 month − 6-K 3 month · filed 2025-06-12 | -$130.54K 6-K · filed 2025-06-12 | -$480.94K derived: sum of 3 quarters · filed 2026-03-12 | -$447.13K derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-01-31 | $69.46K 6-K · filed 2026-03-12 | -$280.94K derived: sum of 2 quarters · filed 2026-03-12 | -$247.13K derived: sum of 3 quarters · filed 2026-03-12 | |
| 2024-10-31 | -$350.40K derived: 20-F 12 month − 6-K 9 month · filed 2026-01-20 | -$316.60K derived: sum of 2 quarters · filed 2026-01-20 | -$238.10K 20-F · filed 2026-01-20 | |
| 2024-07-31 | $33.80K derived: 6-K 9 month − 6-K 6 month · filed 2025-09-11 | $112.30K 6-K · filed 2025-09-11 | ||
| 2024-04-30 | $78.50K 6-K · filed 2025-06-12 | |||
| 2023-10-31 | -$33.91K derived: 20-F 12 month − 6-K 9 month · filed 2026-01-20 | -$26.23K 20-F · filed 2026-01-20 | ||
| 2023-07-31 | $7.69K 6-K · filed 2024-09-16 | |||
| 2022-10-31 | -$5.56K 20-F · filed 2025-01-22 | |||
| 2021-10-31 | -$184.03K 20-F/A · filed 2024-03-18 |